Revised 8/2020

NSG 211 - Health Care Concepts II (5 CR.)

Course Description

Focuses on care of clients across the lifespan in multiple settings including concepts related to psychological and physiological health alterations. Emphasizes the nursing process in the development of clinical judgment for clients with multiple needs. Provides supervised learning experiences in college nursing laboratories, clinical/community settings, and/or simulated environments. Part II of II. Lecture 3 hours. Laboratory 6 hours. Total 9 hours per week.

General Course Purpose

The purpose of this course is to introduce the competent learner to concepts of nursing practice across the lifespan.

Course Prerequisites/Corequisites

Prerequisites: BIO 141 and BIO 142 or BIO 231 and 232. ENG 111, PSY 230, SDV 101 or 100 BIO 150 or BIO 205, CST 110 or 115 or 126 or 229, NSG 100, NSG 106, NSG 130, NSG 152, NSG 170 and NSG 200

Corequisites: required Elective ENG 112 or HIS 101 or MTH 154 or MTH 245, NSG 210

Course Objectives

Upon completing the course, the student will be able to:

  • Apply principles of patient-centered care across the lifespan.
  • Incorporate factors for improvement in client safety for clients across the lifespan.
  • Apply clinical judgment when prioritizing the delivery of client-centered care for clients with multiple needs and in various clinical settings.
  • Incorporate legalethical principles and professional nursing standards in the care of clients.
  • Examine the impact of quality improvement processes, information technology and fiscal resources in the provision of nursing care.
  • Participate as a member of the health care team in the delivery of nursing care across the lifespan.
  • Integrate the principles of pharmacology to the identified concepts for all client populations across the lifespan.
  • Integrate pathophysiology and principles of pharmacology in the delivery of client care in a variety of populations.

Major Topics to Be Included

  • Addiction concept
    • Addiction principles
    • Risk factors related to addiction
    • Prevention of addiction
    • Addiction diagnostic testing
    • Clinical judgment related to addiction
    • Use of interdisciplinary team in delivery of health care
    • Exemplar: Alcoholism, substance abuse, prenatal substance abuse
  • Mood and Affect Concept:
    • Mood and affect principles
    • Risk factors related to altered mood and affect
    • Prevention of altered mood and affect
    • Clinical judgment related to mood and affect
    • Fight or flight response
    • Risk factors related to anxiety
    • Prevention strategies related to anxiety
    • Clinical judgement related to anxiety
    • Pharmacology: Monoamine Oxidase Inhibitors (MAOI), Selective Serotonin Reuptake Inhibitors (SSRI), Selective Norepinephrine Reuptake Inhibitors (SNRI), Tricyclic Antidepressants, Norepinephrine and Dopamine Reuptake, Inhibitors (Bupropion), Lithium; Anticonvulsants: Valprioc acid, Divalproex, Carbamazepine, Gabapentin, Lamotrigine;
    • Exemplars: depression, postpartum depression, bipolar disorder, suicide, personality disorders, generalized anxiety disorder, phobias, obsessive compulsive disorder (OCD), panic disorders, Post-Traumatic Stress Disorder (PTSD), Eating Disorders
  • Psychosis Concept:
    • Psychosis principles
    • Risk factors related to psychosis
    • Prevention of psychosis
    • Clinical judgment related to psychosis
    • Pharmacology: 1st generation antipsychotics- dopamine receptor antagonists (DRA): Adasuve, fluphenazine, Haldol Decanoate, haloperidol, loxapine, loxapine inhaled; 2nd generation antipsychotics-serotonin-dopamine antagonists: asenapine, clozapine, iloperidone, lumateperone, lurasidone, olanzapine, paliperidone, quetiapine; 3rd generation antipsychotics-partial dopamine D2 agonist: Aripiprazole, Cariprazine, Brexipiprazole, Lumateperone; Anticholinergics (Benztropine, diphenhydramine)
    • Exemplar: schizophrenia
  • Anxiety Concept:
    • Fight or flight response
    • Risk factors related to anxiety
    • Prevention strategies related to anxiety
    • Clinical judgment related to anxiety
    • Pharmacology: Benzodiazepines, Anxiolytics (Buspirone, Hydroxyzine)
    • Exemplars: generalized anxiety disorder, phobias, Obsessive Compulsive Disorder (OCD), panic disorders, Post-Traumatic Stress Disorder (PTSD)
  • Cognition Concept:
    • Cognition principles
    • Risk factors related to cognitive alterations
    • Prevention of cognitive alterations
    • Cognitive diagnostic testing
    • Clinical judgment related to cognitive alterations
    • Psychosis principles
    • Risk factors related to psychosis
    • Prevention of psychosis
    • Clinical judgement related to psychosis
    • Pharmacology: Atypical antipsychotic-2nd generation (Risperidone, aripiprazole), Acetylcholinesterase inhibitor (Galantamine), Cholinesterase Inhibitor (Rivastigmine, donepezil), Central nervous system stimulants (Dextroamphetamine, Methylphenidate, Amphetamine)
    • Exemplars: developmental delay: spectrum disorders
    • Attention--Deficit/Hyperactive Disorder (ADHD), delirium, Alzheimer's disease/dementia, Schizophrenia
  • Violence Concept:
    • Violence principles
    • Risk factors related to violence
    • Prevention of violence
    • Clinical judgment related to violence
    • Recognize, intervene, and report abuse
    • Mandatory reporting
    • Exemplars: child abuse, elder abuse, intimate partner violence
  • Sensory Perception Concept:
    • Sensory perception principles
    • Risk factors related to sensory alterations
    • Prevention of sensory alterations
    • Sensory diagnostic testing
    • Clinical judgment related to sensory alterations
    • Pharmacology: Prostaglandin analogs (latanoprost), Alpha Adrenergic agonists (apraclonidine), Carbonic anhydrase inhibitors (acetazolamide), Gabapentin, Tricyclic antidepressants, Topical anesthetic agents, Cholinergic (pilocarpine), Beta-Blockers (timolol maleate)
    • Exemplars: cataracts, glaucoma, hearing loss, peripheral neuropathy
  • Immunity Concept:
    • Immunity principles
    • Risk factors related to altered immunity
    • Prevention of altered immunity
    • Immunity diagnostic testing
    • Clinical judgment related to altered immunity
    • Pharmacology: Antiretroviral therapy: Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors, Protease Inhibitors, Integrase Strand Transfer Inhibitors, Fusion Inhibitor, CCR5 Antagonist, CD4 Post-Attachment Inhibitor; PreP, Antihistamines (diphenhydramine); Antirejection medications for organ transplant: Corticosteroids (prednisone), Calcineurin inhibitors (tacrolimus, cyclosporine), Antiproliferative agents (mycophenolate mofetil, azathioprine, or sirolimus); Epinephrine
    • Exemplars: Human Immunodeficiency Virus Infection and Acquired Immune Deficiency Syndrome (HIV/AIDS), anaphylaxis, systemic lupus erythematosus, organ transplant
  • Inflammation Concept:
    • Inflammation principles
    • Risk factors related to inflammation
    • Prevention of inflammation
    • Inflammation diagnostic testing
    • Clinical judgment related to inflammation
    • Pharmacology: Antacids, Proton Pump Inhibitors, Anti-inflammatory medications, H2-receptor antagonists, Sulfa-free aminosalicylates (mesalamine), Immunomodulators (azathioprine, mercaptopurine, methotrexate, cyclosporine), Anti-tumor necrosis factor (TNF) medications (adalimumab), Disease-modifying antirheumatic drugs (DMARDs)
    • Exemplars: acute inflammation, inflammatory bowel disease, gastroesophageal reflux disease, rheumatoid arthritis